The Missing Medians: Exclusion of Ordinal Data from Meta-Analyses

被引:11
|
作者
Cumming, Toby B. [1 ]
Churilov, Leonid [1 ]
Sena, Emily S. [2 ]
机构
[1] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia
[2] Univ Edinburgh, Ctr Clin Brain Sci, Sch Clin Sci, Edinburgh, Midlothian, Scotland
来源
PLOS ONE | 2015年 / 10卷 / 12期
基金
英国国家替代、减少和改良动物研究中心;
关键词
GENERALIZED ODDS RATIOS; MINI-MENTAL-STATE; EFFECT SIZE; MULTIPLE-SCLEROSIS; CLINICAL-TRIALS; DISEASE; SCALE; STROKE;
D O I
10.1371/journal.pone.0145580
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Meta-analyses are considered the gold standard of evidence-based health care, and are used to guide clinical decisions and health policy. A major limitation of current meta-analysis techniques is their inability to pool ordinal data. Our objectives were to determine the extent of this problem in the context of neurological rating scales and to provide a solution. Methods Using an existing database of clinical trials of oral neuroprotective therapies, we identified the 6 most commonly used clinical rating scales and recorded how data from these scales were reported and analysed. We then identified systematic reviews of studies that used these scales (via the Cochrane database) and recorded the meta-analytic techniques used. Finally, we identified a statistical technique for calculating a common language effect size measure for ordinal data. Results We identified 103 studies, with 128 instances of the 6 clinical scales being reported. The majority-80%-reported means alone for central tendency, with only 13% reporting medians. In analysis, 40% of studies used parametric statistics alone, 34% of studies employed non-parametric analysis, and 26% did not include or specify analysis. Of the 60 systematic reviews identified that included meta-analysis, 88% used mean difference and 22% employed difference in proportions; none included rank-based analysis. We propose the use of a rank-based generalised odds ratio (WMW GenOR) as an assumption-free effect size measure that is easy to compute and can be readily combined in meta-analysis. Conclusion There is wide scope for improvement in the reporting and analysis of ordinal data in the literature. We hope that adoption of the WMW GenOR will have the dual effect of improving the reporting of data in individual studies while also increasing the inclusivity (and therefore validity) of meta-analyses.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Meta-analyses
    Maier, W.
    Moeller, H.-J.
    [J]. NERVENARZT, 2007, 78 (09): : 1028 - +
  • [22] Should systematic reviews and meta-analyses include data from preprints?
    Brietzke, Elisa
    Gomes, Fabiano A.
    Gerchman, Fernando
    Freire, Rafael C. R.
    [J]. TRENDS IN PSYCHIATRY AND PSYCHOTHERAPY, 2023, 45
  • [23] The Rise in Meta-analyses from China
    Ye, Xiao-Fei
    Yu, Dang-Hui
    He, Jia
    [J]. EPIDEMIOLOGY, 2013, 24 (02) : 335 - 336
  • [24] Statistics for quantifying heterogeneity in univariate and bivariate meta-analyses of binary data: The case of meta-analyses of diagnostic accuracy
    Zhou, Yan
    Dendukuri, Nandini
    [J]. STATISTICS IN MEDICINE, 2014, 33 (16) : 2701 - 2717
  • [25] A Meta View on Meta-analyses
    Fleischhacker, W. Wolfgang
    [J]. JAMA PSYCHIATRY, 2017, 74 (07) : 684 - 685
  • [26] Subgroup analyses in individual patient data meta-analyses require improvement
    Koopman, L.
    Van der Heijden, G. J. M. G.
    Glasziou, P. P.
    Grobbee, D. E.
    Rovers, M. M.
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2006, 21 : 72 - 73
  • [27] On the validity of meta-analyses: exhaustivity must be warranted, exclusion of duplicate patients too
    Pambrun, Elodie
    Bouteloup, Vincent
    Thiebaut, Rodolphe
    Asselineau, Julien
    de Ledinghen, Victor
    Perez, Paul
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2010, 63 (03) : 342 - 343
  • [28] A rationale for the meta-analyses (overviews) on individual patient data
    Gueyffier, F
    Boutitie, F
    Cucherat, M
    Boissel, JP
    [J]. EUROPEAN MEDICINES RESEARCH: PERSPECTIVES IN CLINICAL TRIALS, 1996, : 31 - 36
  • [29] Is there bias in the publication of individual patient data meta-analyses?
    Tierney, JF
    Clarke, M
    Stewart, LA
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2000, 16 (02) : 657 - 667
  • [30] Impact of missing individual patient data on 18 meta-analyses of randomised trials in oncology: Gustave Roussy experience
    Fayard, Florence
    Petit, Claire
    Lacas, Benjamin
    Pignon, Jean Pierre
    [J]. BMJ OPEN, 2018, 8 (08):